Pharma Pulse: Long COVID Exercise Win, $150M Gene Editing Play, and Compounding Pharmacy Expansions
Pharma Pulse: US-UK Trade Deal Forces Pricing Shift, as Lilly Deepens GLP-1 Price Cuts and RSV-Asthma Link Confirmed
Pharma Pulse: Medicare Price Cuts and Vaccine Wins
Pharma Pulse: Medicare Price Negotiations Heat Up, as FDA Approves SMA Gene Therapy
Pharma Pulse: RSV Protection Wanes, AstraZeneca Invests Big, and Novo Nordisk Faces Pipeline Setback
Pharma Pulse: AI Drug Discovery Hits Billion-Dollar Scale, as Abbott Is Set to Acquire Diagnostics Giant
Pharma Pulse: Long COVID's Enduring Challenge Amid Major US Manufacturing Surge
Pharma Pulse: Regulatory Crucible, China Supply Risk, and Texting Triumphs in Diabetes Care
Pharma Pulse: Patients Struggle to Identify Safe Online Pharmacies, as Novo Nordisk Launches Access Offers
Pharma Pulse: Rural Vaccine Gaps, Semaglutide Organ-Protective Benefits, and Amazon Pharmacy’s Urgent Care Expansion Shape Healthcare Outlook
Pharma Pulse: Young Adults Skip Cholesterol Care, as Pharmacy Access Gaps Widen and Crypto Enters the Prescription Market
Pharma Pulse: FDA Advances New Approval Pathway, as Obesity Care and Metabolic Treatments Gain Momentum
Pharma Pulse: FDA Appoints Richard Pazdur as CDER Director Amid 340B Tensions and Novartis Expansion
Pharma Pulse: HHS Updates Menopausal Hormone Therapy Labels, as SGLT2 Inhibitors Show Broader Kidney and Heart Benefits
Pharma Pulse: New Research and Policy Moves Shape Pharma Landscape
Pharma Pulse: FDA Expands Priority Voucher Program, as Oral Semaglutide Shows New Benefits and Cost Plus Drugs Adds Starjemza
Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada
Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network
Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches
Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis
Pharma Pulse: Severe COVID-19 Raises Stroke Risk in Asthma Patients, Parents Divided on Vaccine Policies, and 2026 Medicare Rankings Revealed
Pharma Pulse: Cancer Care Gaps Persist, Physician Pay Hits Record Highs, and AstraZeneca Expands Texas Manufacturing
Pharma Pulse: FDA Approves One-Minute HIV Test, US Delays Pharma Tariffs, and CVS Acquires 600 Rite Aid Stores
Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site
Pharma Pulse: CDC Layoffs Raise Public Health Concerns as Ypsomed and Lupin Expand US Manufacturing Footprint
Pharma Pulse: Mark Cuban Disrupts Drug Pricing, AstraZeneca Expands US Manufacturing, and BMS Bets Big on RNA Therapeutics
Pharma Pulse: CDC Updates Vaccine Guidance, GLP-1s Linked to Imaging Challenges, and Novo Nordisk Loses Inflation Reduction Act Appeal
Pharma Pulse: FDA Expands Pediatric UC Treatment Options, AstraZeneca and Algen Partner in Neurology, and Peli BioThermal Boosts Cold Chain Capabilities
Pharma Pulse: Study Links Early Obesity to Postpartum Diabetes Risk, Amgen Launches AmgenNow, and Eli Lilly Strengthens Global Supply Chain
Pharma Pulse: NIAID Whistleblower Controversy, ALS Linked to Autoimmunity, and Hospital Layoffs Accelerate Nationwide
Pharma Pulse: FDA Approves First Generic Mifepristone, Takeda Exits Cell Therapy Research, and SciSafe Expands Biopharma Storage
Pharma Pulse: FDA Faces Shutdown Risks, Aetna Unveils 2026 Medicare Advantage Plans, and US Maternal Mortality Remains High
Pharma Pulse: Telehealth Access at Risk During Shutdown, Medicare Advantage SNPs Surge, and Halozyme Buys Elektrofi for $750M
Pharma Pulse: Trump Plans Direct-to-Patient Website, Gabapentin Prescriptions Surge, and Gene Therapy Slows Huntington’s Progression
Pharma Pulse: Measles Vaccination Gaps Persist, FDA Approves Guselkumab for Children, and AbbVie Expands US Manufacturing
Pharma Pulse: Drug Tariffs Threaten Access, Pediatric Flu Raises Vaccination Concerns, and AbbVie Files NDA for Tavapadon
Pharma Pulse: Medicaid Cuts Threaten Childhood Coverage, Fixed-Dose Combo Reduces Heart Failure in Diabetes, and BMS Expands Sotyktu Access
Pharma Pulse: CDC Expands COVID-19 Vaccine Guidance, Medicare Model Cuts Insulin Costs, and Lilly Invests in Houston Facility
Pharma Pulse: FDA Examines Prenatal Acetaminophen Risks, GSK Files sNDA for Leucovorin, and Celltrion Buys Lilly Plant
Pharma Pulse: CDC Shifts COVID-19 Vaccine Guidance, Pfizer Buys Metsera for Obesity Pipeline, and New Tech Targets GLP-1 Adherence
Pharma Pulse: CDC Delays Hepatitis B Vaccine Vote, Value-Based Care Improves Senior Access, and Takeda Tests Wind-Powered Shipping
Pharma Pulse: GSK Invests $30B in US Manufacturing, GLP-1s Show Heart Benefits, and Roche Buys 89bio for Metabolic Pipeline
Pharma Pulse: CDC Leadership Controversy, Physician Mental Health Challenges, and Eli Lilly’s $5B US Manufacturing Expansion
Pharma Pulse: Parental Vaccine Hesitancy Grows, Federal Vaccine Committee Expands, and Healthcare Workforce Faces Retention Crisis
Pharma Pulse: Rural Hospitals Seek $50B Lifeline, Vaccination Gaps Found in Celiac Patients, and Novartis Signs $5.7B Licensing Deal
Pharma Pulse: FDA Accelerates Non-Opioid Pain Drug Development, FTC Targets Non-Competes in Healthcare, and DHL Expands Last-Mile Logistics
Pharma Pulse: White House Eyes China Drug Restrictions, Pfizer-BioNTech Vaccine Data Strong, and Samsung Biologics Secures US Deal
Pharma Pulse: Measles Outbreak Spurs Vaccine Mandate Debate, Trump Eyes DTC Ad Restrictions, and ICER Reviews GLP-1 Costs
next page